Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

Abstract Zavegepant is a novel gepant administered as a nasal spray approved in the United States at a 10 mg dose for the acute treatment of migraine with or without aura in adults. The cardiovascular safety of zavegepant nasal spray was assessed in both single‐ascending dose (SAD) and multiple‐asce...

Full description

Saved in:
Bibliographic Details
Main Authors: Jim H. Hughes (Author), Richard Bertz (Author), Rajinder Bhardwaj (Author), Mary K. Donohue (Author), Jennifer Madonia (Author), Matt S. Anderson (Author), Beth A. Morris (Author), Robert S. Croop (Author), Jing Liu (Author)
Format: Book
Published: Wiley, 2024-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items